SHAREHOLDERS' EQUITY (Details Textual)		9 Months Ended		12 Months Ended
	Mar. 15, 2024 shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 $ / shares	Dec. 31, 2015 $ / shares	Sep. 30, 2024 ₪ / shares	Sep. 30, 2024 USD ($) shares	Dec. 31, 2023 ₪ / shares shares	Dec. 22, 2022 USD ($)	Jul. 21, 2022 USD ($)	Jun. 02, 2022 ₪ / shares	Jun. 02, 2022 USD ($)	Dec. 28, 2016 USD ($)
Shareholders' Equity
Reverse share split, description		a reverse share split within a range of 1:2 to 1:12, to be effective at the ratio
Maximum number of authorized ordinary shares reverse share split		120,000,000
Issued and outstanding ordinary shares of reverse pre-split shares	60,100,000
Issued and outstanding ordinary shares of reverse post-split shares	8,600,000
Authorized number ordinary shares of reverse post-split shares	25,000,000
Number of share-based outstanding						4,723	4,723
Per share value of stock repurchase authorized | ₪ / shares					₪ 1.75		₪ 1.75
Treasury Stock, Common, Shares						574,658	574,658
Minimum [Member]
Shareholders' Equity
Authorized number ordinary shares of reverse post-split shares	30,000,000
Maximum [Member]
Shareholders' Equity
Authorized number ordinary shares of reverse post-split shares	43,750,000
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 [Member]
Shareholders' Equity
Number of warrants issued						534,300
Proceeds from warrants | $		$ 4,675,125
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]
Shareholders' Equity
Number of warrants issued						288,634
Proceeds from warrants | $		3,556,976
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]
Shareholders' Equity
Number of warrants issued						514,010
Proceeds from warrants | $		4,821,416
Placement agent [Member] | February 2020 best efforts offering [Member]
Shareholders' Equity
Number of warrants issued						32,880
Proceeds from warrants | $		359,625
Placement agent [Member] | December 2020 private placement [Member]
Shareholders' Equity
Number of warrants issued						32,283
Proceeds from warrants | $		$ 405,003
Kreos Capital V [Member]
Shareholders' Equity
Warrants grant date				Dec. 31, 2015
Warrants exercisable, description.		currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of September 30, 2024.
Kreos Capital [Member]
Shareholders' Equity
Exercise price per share | $ / shares				$ 52.5
Drawdown amount under loan agreement | $												$ 8,000,000
Employee Stock Option [Member]
Shareholders' Equity
Award vesting period, description		Options to purchase ordinary shares generally vest over four years, with certain options to non-employee directors vesting quarterly over one year.
Shares reserved for future issuance (in shares)						0	145,560
Unrecognized cost of shares | $						$ 1,700,000
Expected term of shares		2 years 3 months 18 days
Restricted Stock Units (RSUs) [Member]
Shareholders' Equity
Weighted average grant date fair value, options (in USD per share) | $ / shares		$ 4.8	$ 4.69
Restricted Stock Units (RSUs) [Member] | Nonemployee [Member]
Shareholders' Equity
Number of share-based outstanding						0
Share repurchase program [Member]
Shareholders' Equity
Authorized value of stock repurchased | $								$ 5,800,000	$ 8,000,000		$ 8,000,000
Per share value of stock repurchase authorized | ₪ / shares										₪ 0.25
Treasury Stock, Common, Shares						574,658
Total cost | $		$ 3,500,000